Mesenchymal Stem Cells

A recent concise review article in STEM CELLS from the laboratory of Inho Jo (Ewha Womans University, Seoul, Republic of Korea) summarizes the differentiation capacities of tonsil‐derived mesenchymal stem cells (MSCs) and their therapeutic competencies. Oh et al.

Researchers led by James L. Funderburgh (University of Pittsburgh, Pittsburgh, Pennsylvania, USA) recently sought to understand the mechanisms by which corneal stromal stem cells enhance corneal wounding by assessing extracellular vesicles.

A recently published Concise Review from Martin J.

A study appraises the potential of carbon dots as a replacement for quantum dots to transfect siRNA into MSCs to boost chondrogenic differentiation in vivo

Previous studies from the labs of Li Qian (University of North Carolina at Chapel Hill, USA) and

Human umbilical cord tissue represents an excellent source of mesenchymal stem cells (MSCs), and a recent study from the lab of Ian Rogers (Sinai Health System, Toronto, Ontario, Canada) sought to fully characterize can compare cells derived from multiple donors. In their new STEM CELLS Translational Medicine study, Raileanu et al.

A new study demonstrating how TSG-6 regulates stemness and directs cellular functions in mouse MSCs may allow for improved outcomes in human MSC therapies

Children with autism spectrum disorder (ASD) can suffer from immune dysregulation and inflammation, and now, a STEM CELLS Translational Medicine article from the lab of Neil H.

A new STEM CELLS Translational Medicine article from the laboratory of

Recent research from the lab of Sandra Muntión (IBSAL‐Hospital Universitario de Salamanca, Salamanca, Spain) aimed to analyze changes induced in human CD34+ hematopoietic stem/progenitor cells following treatment with extracellular vesicles derived from mesenchymal stem cells (MSC-EVs).